Log In
Print
BCIQ
Print
Print this Print this
 

BART (BRAC analysis large rearrangement test)

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionPredictive test for detecting large genomic rearrangements in the genes involved in hereditary breast and ovarian cancer patients
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict test for breast and ovarian cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today